Kenneth F. Shinozuka
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Psychedelic Therapy: A Primer for Primary Care Clinicians-Mescaline.
Journal: American journal of therapeutics
Published: June 16, 2026
Psychedelic Therapy: A Primer for Primary Care Clinicians-5-Methoxy-N,N-Dimethyltryptamine.
Journal: American journal of therapeutics
Published: February 20, 2026
Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.
Journal: Translational psychiatry
Published: November 13, 2025
Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans.
Journal: Journal of affective disorders
Published: June 21, 2025
Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends.
Journal: American journal of therapeutics
Published: May 08, 2025
MDMA-Assisted Psychotherapy Phase 3 Trial Publication Retractions.
Journal: American journal of therapeutics
Published: April 10, 2025
LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.
Journal: Imaging neuroscience (Cambridge, Mass.)
Published: April 26, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.
Journal: American journal of therapeutics
Published: March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
Journal: American journal of therapeutics
Published: March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
Journal: American journal of therapeutics
Published: March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
Journal: American journal of therapeutics
Published: March 22, 2024
Last Updated: 09/26/2026